Heart failure & cardiomyopathiesGuideline or statement
Monitoring Disease Progression in Patients With Transthyretin Amyloid Cardiomyopathy
- Expert consensus statement
Recommendations
As issued by the authors
Criteria with meaningful thresholds and monitoring frequency recommendations, designed to measure disease progression in ATTR-CM rather than progression of amyloid deposition
Whether disease progression indicates modification of ATTR-CM treatment remains unknown
Original publication
Monitoring Disease Progression in Patients With Transthyretin Amyloid Cardiomyopathy. JACC Heart Fail. Published 1 December 2025. doi:10.1016/j.jchf.2025.102766
Summarised from the published abstract; every number is checked against it